Conditions: Multiple Sclerosis
Keywords: Multiple Sclerosis erythema
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 30
Healthy volunteers: yes

Brief summary:
The primary purpose of this single center, randomized, open label study in relapsing Multiple Sclerosis (MS) patients on PLEGRIDY (peginterferon beta-1a) is to assess the effect of Preparation H (phenylephrine) Maximum Strength Cream compared to no topical treatment of injection site erythema after PLEGRIDY injection.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: No Treatment Arm intervention 2: Topical Preparation H arm
Intervention descriptions: intervention 1: Participants randomized to the control group will have no topical treatment at the injection site of the first full dose of Plegridy. intervention 2: Preparation H (phenylephrine) treatment first full dose incidence injection site reaction.

Protocol document: